Association of Cancer and Its Interaction with Conventional Risk Factors on Cardiovascular Disease Risk
Oncology · 2024
DOI: 10.1159/000536449 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncology, 2024. Verfasst von Yuta Suzuki und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine, The University of Tokyo, Tokyo, Japan. Hauptthemen laut MEDLINE: Neoplasms, Cardiovascular Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Introduction
We sought to examine the association of cancer history with the incidence of individual cardiovascular disease events and to clarify whether the history of cancer modifies the relationship between conventional cardiovascular risk factors and incident cardiovascular disease.
Methods
This retrospective cohort study used the JMDC Claims Database, including 3,531,683 individuals. The primary endpoint was the composite cardiovascular disease outcome, which included myocardial infarction, angina pectoris, stroke, heart failure, and atrial fibrillation.
Results
During a follow-up, 144,162 composite endpoints were recorded. Individuals with a history of cancer had a higher risk of developing composite cardiovascular disease events (hazard ratio [HR] 1.26, 95% confidence interval [CI] 1.22–1.29). The HRs for myocardial infarction, angina pectoris, stroke, heart failure, and atrial fibrillation were 1.11 (95% CI 0.98–1.27), 1.15 (95% CI 1.10–1.20), 1.11 (95% CI 1.05–1.18), 1.39 (95% CI 1.34–1.44), and 1.22 (95% CI 1.13–1.32), respectively. Individuals who required chemotherapy for cancer had a higher risk of developing cardiovascular disease. Although conventional risk factors (e.g., overweight/obesity, hypertension, and diabetes) were associated with incident composite cardiovascular disease even in individuals with a history of cancer, the total population-attributable fractions of conventional risk factors were less in individuals with a history of cancer.
Conclusion
Individuals with a history of cancer (particularly those requiring chemotherapy) have a higher risk of cardiovascular disease. Traditional risk factors are important in the development of cardiovascular disease in individuals with and without a history of cancer. In individuals with a history of cancer, however, the total population-attributable fractions of conventional risk factors decreased.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiovascular Medicine, The University of Tokyo, Tokyo, Japan.
- Center for Outcomes Research and Economic Evaluation for Health, National Institute of Public Health, Saitama, Japan.
- The Department of Advanced Cardiology, The University of Tokyo, Tokyo, Japan.
- Department of Prevention of Diabetes and Lifestyle-Related Diseases, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
- The Department of Cardiology, New Tokyo Hospital, Matsudo, Japan.
- Clinical Research Promotion Center, The University of Tokyo Hospital, Tokyo, Japan.
Zitieren
APA
Suzuki, Y., Kaneko, H., Okada, A., Matsuoka, S., Kashiwabara, K., Fujiu, K., Michihata, N., Jo, T., Takeda, N., Morita, H., Node, K., Yasunaga, H., & Komuro, I. (2024). Association of Cancer and Its Interaction with Conventional Risk Factors on Cardiovascular Disease Risk. Oncology. https://doi.org/10.1159/000536449
Vancouver
Suzuki Y, Kaneko H, Okada A, Matsuoka S, Kashiwabara K, Fujiu K, et al. Association of Cancer and Its Interaction with Conventional Risk Factors on Cardiovascular Disease Risk. Oncology. 2024. doi:10.1159/000536449
BibTeX
@article{Suzuki2024,
author = {Suzuki, Yuta and Kaneko, Hidehiro and Okada, Akira and Matsuoka, Satoshi and Kashiwabara, Kosuke and Fujiu, Katsuhito and Michihata, Nobuaki and Jo, Taisuke and Takeda, Norifumi and Morita, Hiroyuki and Node, Koichi and Yasunaga, Hideo and Komuro, Issei},
title = {Association of Cancer and Its Interaction with Conventional Risk Factors on Cardiovascular Disease Risk},
journal = {Oncology},
year = {2024},
doi = {10.1159/000536449}
}
EUVIMED